IL6 and infection: However, since rapamycin elevated viral ORF1A by 400-fold but only increased cellular IL6 and IFNB1 by 2.5-fold or less, these results suggest that rapamycin increased cellular susceptibility to SARS-CoV-2 infection, while limiting inflammatory cytokine induction in response to infection.